Supply Chain Management in Pharmaceutical Industry in Poland 2008
Posted on: Wednesday, 17 September 2008, 09:01 CDT
Research and Markets (http://www.researchandmarkets.com/research/fbd037/supply_chain_manag) has announced the addition of the "Supply Chain Management in Pharmaceutical Industry in Poland 2008" report to their offering.
Supply chain management in the pharmaceutical industry in Poland 2008 thoroughly examines the most innovative ways of gaining competitive advantage in the pharmaceutical sector. It studies the conditions and the level of advancement of the Supply Chain Management on the Polish market in the context of the best practices employed in Polish enterprises and worldwide. The concept itself is meticulously explained, focusing on drug production in Poland. Key objectives and solutions offered by the SCM in Polish companies are provided on the basis of empirical data gathered specifically for the purpose of this report.
Key Points:
- Companies are looking for 'non product' solutions to enhance their trade attractiveness.
- Logistic operators play an increasingly important role on the pharmaceutical market.
- Interorganisational supply control is rare in the Polish pharmaceutical sector.
- Functional organizational structures dominate in pharmaceutical companies.
The report provides crucial information for anyone involved in supply management in the pharmaceutical sector in Poland and abroad, and particularly for:
- top management of pharmaceutical companies in Poland and abroad
- logistic operators active on the pharmaceutical market and those planning to enter it
- pharmaceutical company managers interested in implementing Supply Chain Management methods
- supply chain managers
- pharmaceutical distributors
- researchers, market analysts and consultants
- academic institutions
- those wanting to gain a thorough understanding of the Supply Chain Management concept.
Executive Summary:
Key sections
Section one analyses the ways pharmaceutical manufacturers manage supply chains. It provides details related to supply chain planning and supply and demand synchronisation. It also discusses SCM impact on customer service, the production and distribution of pharmaceuticals, as well as supply and redistribution.
Section two investigates SCM integration in Polish companies in the context of the best practices employed abroad. It discusses the SCM strategies employed by Polish companies and internal conditions for SCM implementation. It also analyses the integration of SCM processes and their legal framework, comparing loopholes on Polish and foreign markets.
Section three looks into the development of SCM in Polish pharmaceutical companies, focusing on its growth drivers and conditions. It presents SCM as an innovative tool to efficiently improve company competitiveness, and analyses threats and opportunities for SCM growth in Polish pharmaceutical companies.
Report overview
The report opens with an introduction presenting its objectives and target readership. It then introduces research methods employed in the study and provides a summary and a presentation of its most important conclusions. What follows is a thorough analysis of the supply chains used by pharmaceutical manufacturers, with special attention given to the following aspects:
- supply chain planning:
- supply and demand synchronization
- customer service
- distribution
- production
- supply
- redistribution.
It then discusses the integration of SCM within Polish pharmaceutical companies, in the context of the best practices employed worldwide. It focuses on the following elements:
- SCM strategies of Polish pharmaceutical companies
- internal conditions for SCM in Polish pharmaceutical companies
- integration of SCM processes
- loophole analysis:
- Polish companies versus global tendencies.
Finally, the report provides information concerning SCM growth drivers in Polish pharmaceutical
companies. It examines SCM from the following perspectives:
- SCM as a tool to improve competitiveness
- threats and opportunities for SCM growth in pharmaceutical companies in Poland.
Key Topics Covered:
-Report methodology
-Introduction
-Executive summary
-Model of an excellent supply chain in the pharmaceutical industry
-Objective structure of the supply chain
-Selected processes in the pharmaceutical supply chain
-Summary
-Analysis of best practices - selected directions of improving SCM in the Polish pharmaceutical industry
For more information visit http://www.researchandmarkets.com/research/fbd037/supply_chain_manag.
Source: Business Wire
Related Articles
- Governor Granholm Appoints Evans Distribution Systems' President to Supply Chain Management Development Commission
- Impeva Demonstrates 'Smarter' Supply Chain Management Solutions to Help Ensure Safe, Timely Delivery of Critical Supplies for Global Communities
- LOG-NET, Inc. Releases Version 6.5 of Their Leading Supply Chain Management Application
- OraSure Technologies Signs Agreement With the Supply Chain Management System for Supply of OraQuick(R) HIV Test to PEPFAR Countries
- Tech Data Names Brooke D. Powers Senior Vice President, Purchasing and Supply Chain Management
- Angiotech Appoints Victor Diaz As Senior Vice President, Global Manufacturing & Supply Chain Management
- Texas Instruments Outlines Industry-Wide Plan for Securing the Pharmaceutical Supply Chain
- Seeing the Future: Innovative Supply Chain Management Strategies
- Mitrix Provides Kawasaki With New 3.1 On Demand Supply Chain Management Solution
User Comments (0)

RSS Feeds